fiduxosin has been researched along with hmr 3647 in 1 studies
| Studies (fiduxosin) | Trials (fiduxosin) | Recent Studies (post-2010) (fiduxosin) | Studies (hmr 3647) | Trials (hmr 3647) | Recent Studies (post-2010) (hmr 3647) |
|---|---|---|---|---|---|
| 14 | 3 | 5 | 116 | 3 | 36 |
| Protein | Taxonomy | fiduxosin (IC50) | hmr 3647 (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.1 | |
| Bile salt export pump | Homo sapiens (human) | 4.5 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 5.8884 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.4674 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fiduxosin and hmr 3647
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |